Preparation and evaluation of a thermosensitive liposomal hydrogel for sustained delivery of danofloxacin using mesoporous silica nanoparticles by Zahraee Salehi, Taghi. et al.
Iranian Journal of Veterinary Medicine
295IJVM (2016), 10 (4):
Preparation and evaluation of a thermosensitive liposomal hy-
drogel for sustained delivery of danofloxacin using mesoporous 
silica nanoparticles
Kiani, K.1, Rassouli, A.1*, Hosseinzadeh Ardakani, Y.2, Akbari Javar, H.2, Khanamani Falahatipour, 
S.1, Khosraviyan, P.2, Zahraee Salehi, T.3
1Department of Pharmacology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
2Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran 
3Department of Microbiology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran
Abstract:
BACKGROUND: Sustained release delivery system can re-
duce the dosage frequency and maintain the therapeutic lev-
el of drugs for a longer time. Biodegradable, biocompatible 
and thermosensitive chitosan-beta-glycerophosphate (C-GP) 
solutions can solidify at body temperature and maintain their 
physical integrity for a longer duration. OBJECTIVES: To de-
velop a novel delivery system based on the integration of 
liposomes in hydrogel using mesoporous silica nanoparti-
cles (MSNs) for sustained release of danofloxacin in farm 
animals. METHODS: The MSNs were prepared using N-cet-
yltrimethylammonium bromide and tetraethylortho silica. 
The liposomes were prepared by thin film hydration method. 
C-GP solution containing danofloxacin-loaded MSN lipo-
somes underwent different in-vitro tests, including evalua-
tion of the entrapment efficiency, gelation time, morphology, 
drug release pattern as well as antimicrobial activities against 
S. aureus and E. coli. RESULTS: The mean pore size of MSNs 
was 2.8 nm and the mean MSN entrapment efficiency was 
45%. Kinetics of danofloxacin release from liposomal hy-
drogel followed the Higuchi’s model. This formulation was 
capable of sustaining the danofloxacin release for more than 
96 h. The FTIR studies showed that there were no interac-
tions between danofloxacin and hydrogel  excipients. Scan-
ning electron microscopy (SEM) showed that the formed gel 
had a continuous texture, while the swelled gel in the phos-
phate buffer had a porous structure. Microbiological tests 
revealed a high antibacterial activity for lipomosal hydrogel 
of danofloxacin-loaded MSN comparable with danofloxacin 
solution. CONCLUSIONS: The liposomal hydrogel solidified at 
body temperature, effectively sustained the release of dano-
floxacin and showed in vitro antibacterial effects.
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Introduction
Controlled release parenteral dosage 
forms of antibiotics have many applications 
in veterinary medicine since therapeutic 
levels of antibiotics could be maintained 
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without the need for repeated injections 
(Medlicot et al., 2004). Recently, a consid-
erable interest has  focused on injectable, in 
situ forming gel for drug delivery. Hydro-
gels are three dimensional hydrophilic poly-
mer networks capable of absorbing large 
amounts of water or biological fluids (Patois 
et al., 2009). Chitosan is obtained from chi-
tin by alkaline acetylation, and it has many 
desirable properties including biocompat-
ibility, biodegradability and high safety 
profile (Chang et al., 2009). The hydrogen 
bonding in chitosan chains due to the pres-
ence of amine and hydroxyl groups causes 
the chitosan solutions to be highly viscous 
(Bhupendra et al., 2011). A thermosensitive 
neutral solution based on chitosan/β-glycer-
ophosphate was first reported by Chenite et 
al. (2001) and has recently become a major 
area of research. The neutral solution of chi-
tosan and β-glycerophosphate remains liq-
uid at room temperature but changes into a 
gel at body temperature (Khodaverdi et al., 
2012). The in situ gelation mechanism in-
volves neutralization of ammonium groups 
in chitosan, and strengthening of hydro-
phobic and hydrogen bonding between the 
chitosan chains at elevated temperatures 
(Chenite et al., 2001).
Since drug-loaded particles are suitable 
for controlled release and drug targeting, 
they have also been the focus of research 
in drug delivery systems. Among them, 
MSNs offer several attractive features, such 
as having a large surface area, being easily 
modified, pore size and volume, as well as 
being chemically inert and allowing easi-
er functionalization of their surface. All of 
these features provide better control of drug 
loading and release profile. MSNs could be 
administered through parenteral and oral 
routes (Mohseni et al 2015).
Even though  toxicity of silica nanoparti-
cles is a concern, many studies have shown 
that this concern is not serious. For exam-
ple, one study has shown that single and re-
peated intravenous doses in mouse caused 
no death (Liu et al., 2011).
Liposomes are colloidal vesicular struc-
tures of one or more lipid bilayers surround-
ing an aqueous compartment. A conven-
tional drug injected into the blood stream 
typically achieves therapeutic level rapidly 
but keeps this level just for a short duration 
due to metabolism and excretion. Drug en-
capsulated by liposomes maintains its thera-
peutic level for a longer duration as the drug 
must first be released from the liposomes 
before being exposed to the metabolism and 
excretion processes (Shashi et al., 2013). 
Danofloxacin, as a third fluoroquinolone 
antibacterial drug, acts by inhibition of bac-
terial DNA-gyrase. It has a rapid bactericid-
al activity against numerous Gram-negative 
and some Gram-positive bacteria, myco-
plasmas and intracellular pathogens like 
Brucella and Chlamydia species (Yang et 
al., 2014). It has also shown excellent activ-
ity against respiratory pathogens of cattle, 
swine and poultry. Among the various drug 
delivery systems considered for pulmonary 
infections, nanoparticles have demonstrated 
several advantages, such as prolonged drug 
release, cell-specific targeted drug delivery 
or modified distribution of drugs, both at 
cellular and organ level (Beck-Broichsitter 
et al., 2009). For this purpose, MSNs with 
pore sizes in the range from 1 to 3 nm were 
synthesized. Due to high water solubility 
of danofloxacine, drug-loaded MSNs were 
encapsulated in liposomes and then add-
ed to chitosan/β-GP hydrogel. The release 
behavior of liposomal hydrogel containing 
danofloxacin-loaded MSNs as well as its 
Preparation of a liposomal hydrogel, danofloxacin Kiani, K.
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morphology, gelation time and antibacterial 
activities were studied.
Materials and Methods
Medium molecular weight chitosan, 
with a degree of deacetylation (DDA) of 
75-85% and β-Glycerophosphate disodi-
um salt pentahydrate, were purchased from 
Sigma-Aldrich Chemical Co. (St. Louis, 
USA). Cetyltrimethylammonium bromide 
(CTAB, 98%) was purchased from Merck 
(Darmstadt, Germany). Tetraethyl orthosili-
cate (TEOS, 99%), egg phosphatidil choline 
and cholesterol were purchased from Sigma 
Aldrich (Seelze, Germany). Danofloxacin 
mesylate was provided by Kimiafaam Phar-
maceutical Co. (Tehran, Iran). Acetic acid 
was purchased from Merck. All other chem-
icals were reagent grade.
Synthesis and characterization of 
MSNs: At first, N-cetyltrimethylammoni-
um bromide (CTAB, 1.00 g, 2.75 mmol) 
was dissolved in 480 ml of deionized water, 
and then, 3.5 ml of NaOH (2.0 M) was intro-
duced to the CTAB solution at 80 ºC. After 
increasing the temperature to 80 ºC, TEOS 
(5 mL, 21.9 mmol) was added drop-wise at 
a rate of 1mL/ min to the previous solution. 
The reaction mixture was stirred vigorously 
at 80 ºC for 2 h. The white precipitate was 
isolated by filtration. Nanoparticles were 
washed with water and methanol and then 
dried under vacuum at 80 ºC for 24 h. The 
surfactant was removed via calcination of 
the obtained powder. The powder was heat-
ed to 540 ºC with a heating rate of 1 ºC/min 
and then at 540 ºC for 4 h. The surface area 
and pore size of MSNs were determined us-
ing a N2 adsorption-desorption instrument 
(Quanta chrome NOVA Automated Gas 
Sorption System, 2000e, USA). 
Development of liposomes containing 
danofloxacin-loaded MSNs: Prior to lipo-
some fusion, MSN (100 mg) was incubated 
with danofloxacin in 5.0 mL of water (10 
mg/mL) for 24 h at room temperature. After 
stirring for 24 h under light-sealed condi-
tions, the danofloxacin-loaded MSNs were 
centrifuged and washed with 20 mL of ace-
tonitrile. To evaluate the danofloxacin load-
ing efficiency, the supernatant was collect-
ed, and the residual danofloxacin content 
was determined by a UV spectrophotometer 
at 276.8 nm. The loading capacity of dano-
floxacin (Dano) was calculated by the fol-
lowing equation: 
Loading capacity (%) = [(initial Dano 
(mg)- Dano in supernatant (mg)) / weight of 
formualation (mg)] * 100               
The liposomes were prepared by a lip-
id-film based method (Sharma, 1997). Brief-
ly, 50 mg of L-α-PC (phosphatidyl choline) 
and 10 mg of cholesterol were dissolved in 
5 ml of chloroform   and evaporated to form 
a thin lipid film with a rotary evaporator. 
Then, the formed lipid film was re-hydrated 
in 10 ml of distilled water prior to loading 
the danofloxacin in MSNs and was sonicat-
ed for 15 min. Finally, the mixture was cen-
trifuged at 10,000 rpm for 30 min.
Preparation of hydrogel: Chitosan pow-
ders (250 mg) were dissolved in 6 ml of 0.1 
M acetic acid and were gently stirred for 3 
h to make a homogeneous solution. Then li-
posomes were fused with the chitosan solu-
tion and stirred for another 1 h. To make the 
β-GP solution, 1000 mg of β-GP was dis-
solved in deionized water. The chitosan and 
β-GP solutions were placed separately in an 
ice-water bath at 4 ºC for 15 minutes. Then 
the β-GP solution was added drop-wise to 
the chitosan/liposome solution and stirred 
for 30 min. 
Kiani, K.
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Determination of gelation time: In the 
present study, gelation time was assessed 
using the inverted tube test, as described by 
Gupta and coworkers (Zhou et al., 2011). 
When a test tube containing a solution is 
titled, it is defined as a sol phase if the solu-
tion is deformed by the flow, or a gel phase 
if there is no flow. Firstly, 2 ml of the chi-
tosan/ β-GP solutions was maintained for 12 
h at 4ºC in 5 ml vials with inner diameters 
of 10 mm to remove air bubbles. The vials 
were then incubated in a temperature-con-
trolled bath. The sol-gel transition time was 
determined by inverting the vials horizon-
tally every minute. The time at which the 
gel did not flow was recorded as the gela-
tion time.
Standard calibration curve of dano-
floxacin: To construct the calibration curve, 
the danfloxacin solutions were prepared in 
a phosphate buffer, with a pH of 7.4, at a 
concentration range of 2.5 - 15.0 μg/ml. The 
absorbance of the solutions was measured 
at 276.8 nm using a UV-Vis spectrophotom-
eter (Fig. 1).
In-vitro drug release study: The release 
profile of danofloxacin loaded in MSNs 
was investigated in phosphate buffer solu-
tion (PBS) as the test medium. Accurately 
weighed amounts of the prepared sample 
(1.0 g) were used under sink conditions at 37 
oC. At predetermined time points up to 168 
h, 1 ml of the release medium was collect-
ed and replenished with fresh buffer phos-
phate. The collected samples were analyzed 
with a UV spectrophotometer. The amount 
of the released drug (mg) was calculated by 
comparing its absorbance, at 276.8 nm, to 
the absorbance of a 10 mg/ml solution of 
danofloxacin in PBS. All measurements 
were performed in triplicate. Data are re-
ported as means ± SD.
Morphological study: To maintain the 
porous structure of the hydrogels, they were 
freeze-dried first and then SEM was per-
formed. The samples were plunged in liq-
uid nitrogen, and the samples were cut with 
a cold knife. They were mounted on the 
plate base and coated with platinum-gold 
for SEM imaging, at 30 kV, using a scan-
ning electron microscope (FESEM, Hitachi. 
S4160, Japan).
FTIR spectra analysis: The chitosan, 
β-GP, and dried chitosan/β-GP gel were 
placed in KBr pellets (the samples were 
mixed with KBr, with a ratio of 1:100, and 
pressed to form pellets) and were studied 
using an FTIR spectrophotometer (Nicolet, 
Model Impact 410; Madison, WI), in the 
range of 400-4000 cm-1 and at room tem-
perature.
Microbiological tests: To determine the 
antibacterial activity of danofloxacin lipo-
some hydrogel, the well diffusion test was 
carried out using Escherichia coli (E.coli) 
ATCC10145 as a Gram-negative patho-
genic strain and Staphylococcus aureus (S. 
aureus) ATCC29213 as a Gram-positive 
pathogenic strain. The bacterial suspen-
sions with a cell density of 0.5 McFarland 
(1.5 ×108 CFU/ml) were transferred onto 
the surface of Muller-Hinton agar plates us-
ing sterile cotton swabs. Wells with diame-
ters of 8 mm were prepared by punching a 
sterile cork borer onto the solid agar medi-
um. Aliquots (20 µl) of the danofloxacin gel 
(containing 20µg/ml of the drug) for dano-
floxacin hydrogel, danofloxacin suspension 
as positive control, the blank preparation 
(formulated exactly in the same way as the 
drug formulation but without adding dano-
floxacin) as a control to investigate the an-
timicrobial properties of chitosan and other 
ingredients were poured into the wells. The 
Kiani, K.
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plates were kept for 30-60 min in an upward 
position to facilitate the distribution of the 
formulations in the media. After incubation 
for about 24 h, at 37 °C, the zones of in-
hibition around the wells were measured in 
mm using a caliper. All experiments were 
carried out in triplicate (Jahangirian et al., 
2013). 
Results
In-vitro drug release: As shown in Fig 
2, a prolonged release pattern was observed 
for danofloxacin. About 27% of the drug 
was released within 24 h from the formula-
tion and nearly 70% of the loaded drug was 
released within 96 hours. No burst effect 
was seen.
The release kinetic pattern of the drug 
from the prepared hydrogel was analyzed 
and the best method for this formulation 
was determined using a regression coeffi-
cient (r2) close to 1. The values for r2 were: 
Zero Order model, 0.90701; First Order 
model, 0.6645; Higuchii model, 0.9827; 
Hixon-Crowell model, 0.8339 and Kors-
meyer-Peppas, 0.7574. According to the re-
gression coefficient values, the drug release 
data best fit with Higuchi’s kinetic model. 
The most familiar form of Higuchi’s mod-
el is the simplified Higuchi model, which 
relates drug concentration to the square root 
of time:
Mtgel=kHt1/2 
where Mtgel is the concentration of the 
drug in the drug matrix at time t and KH is 
the Higuchi dissolution constant (Singhvi et 
al., 2011)
Gelation time: The gelation process of 
liposomal hydrogel formulation was tem-
perature- and time-dependent. By raising 
the temperature, the gelling process accel-
erated; by increasing the temperature from 
32 to 37oC the solidification time of the hy-
drogel was reduced from 30 to 15 min, and 
above 37oC, increasing the temperature did 
not change the time of gelling. The sol to 
gel transition at room temperature is illus-
trated in Fig 3.
Fourier transform infrared spectros-
copy (FTIR) studies: The FTIR spectra 
of the lyophilized chitosan, β-GP, chitosan/ 
β-GP, danofloxacin and liposomal hydrogel 
immediately after the gelation showed that 
there were no interactions between dano-
floxacin and excipients. 
In the range of 2850- 2950 cm-1, the spec-
trum of chitosan has one asymmetric band, 
at 2923 cm-1. This band probably consists of 
two overlapping bands which represent the 
stretching vibrations in the aliphatic groups 
(-CH2 and -CH3) which are characteristic 
of the pyranose ring of chitosan. 
The spectrum of chitosan shows a band 
at 16503 cm-1 which is assigned to the C=O 
stretch of the amide bond and at 1595 cm-1 
which is assigned to the NH2 group of chi-
tosan. These bands indicate that chitosan is 
a partially deacetylated product of chitin. 
In this range of frequency, no significant 
changes were observed.
In the range of 1200- 1500 cm-1, the chi-
tosan molecule showed four peaks, with the 
bands being 1255, 1315, 1380 and 1423cm-
1. The bands at 1423 and 1315 cm-1 are as-
sociated with the oscillations characteristic 
of C-H bending of CH2 groups. The band at 
Kiani, K.
Table 1. In-vitro antibacterial activity of danofloxacin gel 
and danofloxacin solution as positive control (20µg/ml) 
against S. aureus and E. coli bacteria. * Data are expressed 
as mean ± standard deviation, n=3.
Bacteria Zone of inhibition (mm)
Danofloxacin gel Control positive
S. aureus 29.0±0.5 32.0±4.5
E. coli 36.0±1.0 40.0±2.9
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1380 cm-1 represents the C-O stretching of 
the primary alcoholic group -CH2-OH.
In the wave length range of 800- 1200 
cm-1, the FTIR spectrum of chitosan showed 
three bands at 894,1030 and 1155 cm-1. The 
wide band at 1030-1155 cm-1 represents the 
Kiani, K.
Figure 1. Calibration curve of danofloxacin in the phos-
phate buffer.
Figure 3. The chitosan/GP formulation at room tempera-
ture (left) and at 37°C (right).
Figure 5. Pore size distribution of the prepared drug-free 
MSNs.
Figure 4. BET plot of the prepared MSNs.
Figure 6. Nitrogen adsorption (A)/desorption (D) isotherm 
of the prepared MSNs.
Figure 2. In vitro drug release profile of danofloxacin from 
the hydrogel.
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bridge C-O-C stretch of the glucosamine 
residues. 
Two characteristic bands of GP appear 
at 976 cm-1 and 1069 cm-1; the band at 976 
cm-1 indicates aliphatic P-O-C stretching; 
the band at 1069 cm-1 is characteristic of the 
-PO42- group and the band at 920 cm-1 may 
indicate the presence of the -HPO42- group. 
The FTIR spectrum of the chitosan/β-GP 
system after the gelation indicates char 
acteristic bands for chitosan and glycerol 
phosphate disodium salt and there were no 
additional bands. For the chitosan/β-GP sys-
tem, the bands of chitosan at 1380 and 1315 
cm-1 were shifted to 1385 and 1319 cm-1, 
respectively and the bands of GP at 1076 
and 971cm-1 were shifted to 1069 and 976 
cm-1.  No significant differences were seen 
on the FTIR spectra between the hydrogel 
and those of the danofloxacin, chitosan and 
β-GP.
Nanoparticle characterization: The 
Brunauer- Emmett- Teller (BET) surface ar-
eas and the BJH pore size distributions for 
NH2-MSN are shown in  Fig. 4 and Fig. 5. 
The BET curve for MSN exhibited type-IV 
adsorption-desorption isotherm pattern ac-
cording to IUPAC nomenclature for porous 
samples. The BET surface area for MSN 
was found to be 890.54 m2/g. The BJH pore 
size distributions for MSN showed 2.8 nm 
(Fig 5).  The porous nature of the MSN was 
confirmed using nitrogen adsorption-de-
sorption isotherms plot (Fig 6).
Morphology: The SEM photograph 
of the liposomal hydrogel shows that the 
formed gel had a rough and non-porous sur-
face, while the swelled hydrogel in the phos-
phate buffer (pH=7) had a porous structure, 
as shown in Fig 7.
Antimicrobial activity: The antibacterial 
activities of the danofloxacin hydrogel and 
danofloxacin solution as diameter of their 
zones of inhibition against S. aureus and 
E. coli are shown in Table 1. No inhibition 
zone was observed for the gel without dano-
floxacin (the blank preparation).
Discussion
The aim of this study was to prepare a 
novel formulation of danofloxacin as a third 
generation fluoroquinolone antibacterial 
drug for sustained release drug delivery in 
veterinary medicine. In the present study on 
drug release, there was no prominent burst 
effect and the pattern of the release showed a 
smooth and sustained release with 27% and 
53% of the cumulative in-vitro drug being 
released by the end of 24 and 48 h, respec-
tively, although the release continued with 
a lower rate up to 168 h (85%). Regarding 
the kinetics of drug release and according 
to regression coefficient values, the drug re-
lease from the formulation was best fitted 
to Higuchi’s kinetic model. This sustained 
release parenteral dosage form could be de-
sirable for farm animals because it demon-
strates minimized need for repeated injec-
tion, more compliance on drug therapy with 
promisingly better pharmacokinetic profile 
Kiani, K.
Figure 7. SEM of freeze-dried liposomal hydrogels (a) and 
swelled hydrogel in the phosphate buffer (b).
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and antimicrobial efficacy in comparison to 
conventional dosage forms.
The injectable liposomal hydrogel has 
opened up a novel line of research in the 
field of minimally invasive and in situ 
forming gels as it can sustain the release of 
low-molecular weight hydrophilic drug-like 
danofloxacin for more than 96 h. Moreover, 
the system is biodegradable, biocompati-
ble, and devoid of surfactants, and it shows 
minimal mechanical irritation upon in vivo 
implantation because of its soft and elastic 
nature. This type of formulation was pre-
pared for cytarabine to reduce dosage fre-
quency and sustain drug action (Mulik et 
al., 2009). It was capable of maintaining 
the therapeutic serum levels of cytarabine 
for more than 60 h. Thirumaleshwar et al. 
(2012) also designed a liposomal hydrogel 
as a wound dressing to provide an effective 
barrier to prevent the infection of the wound 
and further progression of infection to deep-
er tissues. Khaled et al. (2010) prepared an 
ocular prolonged-release liposomal hydro-
gel containing ciprofloxacin which effec-
tively increased the ocular bioavailability of 
ciprofloxacin. 
Drug release rate can also be controlled 
by functionalization of MSNs. For exam-
ple, the release of vancomycin from cad-
mium sulfide (CdS) capped mobile crys-
talline material 41 (MCM-41) type MSNs 
was shown to be extended for up to 3 days 
and the loading and release mechanism of 
the MSN system was based on the capping 
and uncapping of the openings of the mes-
opores with CdS nanoparticles (Lai et al., 
2003). A controlled release of captopril us-
ing MCM-41 showed enhanced release pro-
file upon silylation and it is suggested that 
the drug release profile can be controlled 
by tailoring the surface properties and pore 
size (Qu et al., 2006). Amine functionalized 
Santa Barbara-type mesoporous particle-15 
(SBA-15) MSNs’ release of tetracycline 
(TC) was shown to be extended up to 48 
h and the TC-MCM-41 nanoparticles were 
more efficient than the free TC against E. 
coli in culture over a period of 24 h (Hashe-
mikia et al., 2015). Thus, drug release could 
potentially be extended from our materials 
through surface functionalization.
In this study, the solidification of the liq-
uid hydrogel was time- and temperature-de-
pendent. All samples had the same gelation 
time above 37°C, lasting for about 15 min. 
By increasing the temperature from 32 to 
37°C the gelation process was accelerated. 
It seems this process occurs via the creation 
of junction zones of the polymers mainly 
with changes in attractive versus repulsive 
forces like electrostatic repulsion between 
chitosan chains and strong chitosan-wa-
ter interactions. These interactions were as 
a result of the polyol part of glycerophos-
phate which protects the chains against ag-
gregation at low temperature. By increasing 
the temperature, chitosan chain polarity 
is reduced, protons from chitosan amine 
groups transfer to the phosphate moiety of 
glycerophosphate, sheets of water mole-
cules around chitosan chains are removed 
and consequently attractive interchain hy-
drophobic and hydrogen bonding forces are 
strengthened to form hydrogel (Chenite et 
al., 2001).
Ruel Gariepy et al. (2002) reported that 
thermosensitive chitosan-beta-glycerophos-
phate (C-GP) solution containing loaded li-
posomes remained in sol state at 8-15°C and 
turned into a gel at body temperature after 
SC/IM injection. This system is reported to 
be able to sustain the drug release for more 
than 2 weeks. The major advantage of com-
Kiani, K.
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bining liposomes with the C-GP hydrogel 
system is the more sustained release of the 
drug along with overall stability compared 
with liposomal suspension. Moreover, this 
formulation offers some advantages over 
other systems. Zentner et al. (2001) report-
ed that the onset of gelation of PLA- PEG- 
PLA was at 14°C and the transition to the 
solid-like gel state was complete around 
18°C; this transition temperature which is 
very close to room temperature complicates 
handling of the preparation but our formula-
tion remains liquid at room temperature for 
several hours and thus is easily injectable.
One of the main objectives of the cur-
rent study was to prepare MSNs with an 
increased specific surface area and pore 
volume in order to achieve high loading of 
drug molecules. The chosen MSNs present-
ed a high surface area and good pore vol-
ume, prior to the loading studies. Passive 
loading was chosen as the preferred method 
to load drug molecules and to increase the 
loading efficiency. In this study, the mean 
loading efficiency was about 45%. Hashe-
mikia et al. (2015) reported TC loading in 
SBA-15 type MSNs as 42.3% w/w.
Among the factors affecting the loading 
process is the polarity of the organic solvent 
(Charnay et al., 2004). The chosen solvents 
were deionized water with a polarity index 
of 10.1. Since the interaction between water 
and silica nanoparticles prevents the load-
ing process, a better choice may be meth-
anol with a polarity index of 5.1. In addi-
tion, time and temperature also influence 
the loading process and should be further 
investigated.
The microbiological study showed an ef-
fective inhibitory property of this formula-
tion on both Gram positive and Gram neg-
ative bacteria. The results showed that the 
inhibition zones of danofloxacin solution 
(positive control) were slightly greater than 
those of danofloxacin hydrogel. This may 
be due to the fact that the drug was not com-
pletely released within 24 hours and there-
fore produced lower danofloxacin concen-
trations in this in vitro test. 
No drug delivery system is faultless, and 
this is the case with liposomal hydrogel as 
well. The cost of this drug delivery is high 
because of high costs associated with the 
raw materials as well as expensive equip-
ment needed to increase manufacturing. 
Another issue is complication with steril-
ization of liposomes. As they are sensitive 
to high temperature, it is better for the ini-
tial solutions to be filtered through 0.45 µm 
and thereafter the entire production process 
to be performed under aseptic conditions 
(New, 1990).
Conclusion: In the present study, the lipo-
somal hydrogel was solidified at body tem-
perature with an appropriate gelation time. 
This promising formulation was capable of 
sustaining the release of danofloxacin for 
more than 96 h and showed suitable in vitro 
antibacterial effects. Although most nov-
el antimicrobial drug delivery systems are 
currently in preclinical stages, with ongoing 
efforts in this field, nanoparticle-based drug 
delivery systems will improve the practice 
of antimicrobial therapy in veterinary med-
icine.
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تهیه و ارزیابی یک هیدروژل لیپوزومی حساس به حرارت برای دارورسانی آهسته 
رهش دانوفلوکساسین با استفاده از نانوذرات سیلیکای مزوپوروس
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 چکیده 
زمینه مطالعه:  ســامانه های دارورســانی آهســته رهش می توانند دفعات تجویز را کاهش داده و عیارهای درمانی دارو را برای 
مدت های طولانی تر حفظ نمایند. محلول های زیست تخریب پذیر، زیست سازگار و حساس به حرارت  کیتوزان- بتا گلیسروفسفات 
در دمای بدن ژله ای شــده و برای مدت طولانی قادر به حفظ یکپارچگی خود می باشــند. هدف: ساخت یک سامانه دارورسانی جدید 
آهسته رهش دانوفلوکساسین بر پایه ترکیب لیپوزوم و هیدروژل با استفاده از نانوذرات سیلیکا برای مصرف در حیوانات مزرعه می باشد. 
روش کار: نانوذرات سیلیکای مزوپوروس با استفاده از ستیل تری متیل آمونیوم و تترا اتیل اورتوسیلیکا و لیپوزوم ها به روش هیدراسیون 
لایه نازک تهیه شدند. محلول های کیتوزان-بتا گلیسرو فسفات حاوی لیپوزوم های دانوفلوکساسین بار شده در نانوذرات سیلیکا تحت 
ارزیابی های مختلف از جمله الگوی رهایش دارو، زمان ژله ای شدن، میزان بارگیری در نانوذرات، ریخت شناسی و آزمایشات فعالیت 
ضدمیکروبی علیه استافیلوکوک اورئوس و اشریشیا کلای قرار گرفتند. نتایج: میانگین اندازه حفرات نانوذرات mn 8/2 و میانگین 
کارآیی بارگیری دارو در نانو ذرات 54% بود. کینتیک رهایش دارو از مدل هیگوشــی پیروی کرده و قادر به رهایش دانوفلوکساســین 
به مدت بیش از 69 ســاعت بود. براســاس مطالعات انجام شده هیچ برهمکنشی بین دانوفلوکساسین و سایر اجزا ژل وجود نداشت. 
میکروسکوپ الکترونی نگاره ساختار یکنواخت و غیرمتخلخلی را برای ژل نشان داد، در حالی که ژل متورم شده در بافر فسفات دارای 
ساختار متخلخل بود. آزمایشات میکروبی فعالیت بالای ضدباکتریایی هیدروژل لیپوزومی دانوفلوکساسین و قابل مقایسه با محلول 
دانفلوکساسین را نشان داد. نتیجه گیری نهایی: هیدروژل لیپوزومی دانوفلوکساسین در دمای بدن جامد شد و بخوبی قادر به آهسته 
رهش کردن دارو و نشان دادن اثرات ضدباکتریایی در محیط آزمایشگاهی بود.  
واژه های کلیدی:  دانوفلوکساسین، دارورسانی، لیپوزوم، نانوذرات سیلیکای مزوپوروس، حساس به حرارت   
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